[Therapeutic management of neurodermatitis atopica].
The therapy of atopic dermatitis remains a challenge. The success of any therapeutic concept is based on a broad and early diagnostic approach which allows to rule out relevant provocation factors and allergens. During remission periods the regular use of a topical basic therapy consisting of drug-free emolients is recommended. Topical corticosteroids as well as systemic or local antimicrobial therapy and antihistamines are essential during periods of acute exacerbations. Although during the last years a great number of new therapeutic approaches have been published, data of most of these therapeutic modalities are not sufficient to allow an unrestricted use in all patients with atopic dermatitis.
Kägi
M K
MK
Dermatologische Klinik, Universitätspital Bern.
D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects; D003876:Dermatitis, Atopic / Q000188:drug therapy* / Q000209:etiology; D003879:Dermatologic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D004643:Emollients; D006634:Histamine H1 Antagonists / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D013256:Steroids
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D003879:Dermatologic Agents; D004643:Emollients; D006634:Histamine H1 Antagonists; D013256:Steroids
Therapeutisches Management der Neurodermitis atopica.